The decrease in the level of 1,25(OH)2D3, reduction in expression of soluble Klotho, activation of the renin-angiotensin system, increase in sodium retention in the kidneys, increase in inflammatory markers, and hypophosphatemia could be explanations for the effect of FGF23 on the cardiovascular system. Here, KL is linked to hypophosphatemia.